Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/30/2012CN102475682A 小檗碱脂质体及其制备方法 Berberine liposomes and its preparation method
05/30/2012CN102219851B Preparation method for insulin glargine crystals
05/30/2012CN102188565B Weight-losing soft capsules and preparation method thereof
05/30/2012CN102145125B Propolis and aweto capsule for treating diabetes
05/30/2012CN102133298B Two-aqueous-phase method for extracting total saponin from bittersweet herb
05/30/2012CN102133221B Compound traditional Chinese medicine extract preventing glucose metabolism disturbance and preparation method thereof
05/30/2012CN102101661B Method for preparing high-purity monopotassium phosphate crude medicine
05/30/2012CN102085226B Japanese picris japonica extract and extracting method thereof
05/30/2012CN102078402B Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia
05/30/2012CN102078383B Compound ginkgo leaf capsule and tablet preparation method
05/30/2012CN102078345B Preparation method of actinidia arguta flavonoids
05/30/2012CN102078304B Insulin drug carried microspheres and preparation method thereof
05/30/2012CN102076346B Pharmaceutical compositions for human and preparation of bismuth or zinc agent
05/30/2012CN102048786B Preparation and application of coreopsis extract
05/30/2012CN102031229B Lactobacillus plantarum with gastrointestinal adsorption capacity and cholesterol removing capacity
05/30/2012CN102028849B Chinese medicinal composition and preparation method thereof
05/30/2012CN102028725B Traditional Chinese medicine composition, extract, preparation method and application thereof
05/30/2012CN101987188B Biological Chinese patent drug for preventing and treating hyperlipoidemia
05/30/2012CN101982200B Rhizoma coptidis total alkaloids resin complexes, sustained-release preparation thereof and preparation method thereof
05/30/2012CN101978975B Haematococcus extract preparation, and preparation method and use thereof
05/30/2012CN101974034B Method for synthesizing flavone alkyl phosphate compound and application thereof in cholesterol esterase inhibitor medicine
05/30/2012CN101961336B Medicainal composition for treating type 2 diabetes of mammals including human beings
05/30/2012CN101953820B Application of styrene phenol compounds to preparing insulin sensitizer
05/30/2012CN101935359B Liriope muscari baily polysaccharide and preparation method thereof
05/30/2012CN101897832B Medlar reactant
05/30/2012CN101856351B Composition and use thereof in preparation of RXR receptor transcription inhibitor
05/30/2012CN101829271B Chinese medicinal compound with function of treating diabetes and preparation method and application thereof
05/30/2012CN101810775B Chinese medicinal composition for reducing sugar and dripping pills
05/30/2012CN101805336B Compound containing tryptophane and isoxazole skeleton and preparation method and application thereof
05/30/2012CN101798347B Monoclonal antibody for resisting high mobility group protein B1
05/30/2012CN101780067B Pharmaceutical composition for treating diabetic nephropathy and preparation method and application
05/30/2012CN101766678B Application of total flavonoid in astragalus to preparing medicaments for preventing and controlling diabetes and nephropathy
05/30/2012CN101766258B Pig feed additive and application thereof
05/30/2012CN101744844B Fulvic acid or sodium fulvate substance with hypoglycemic function
05/30/2012CN101732267B Pravastatin sodium tablet as well as application and preparation method thereof
05/30/2012CN101723947B Dipeptidase-IV inhibitor compound
05/30/2012CN101721432B Giant salamander oil soft capsule, method for preparing same and use thereof
05/30/2012CN101646678B Heteroaryl derivative
05/30/2012CN101602768B Method for purifying sesamin and sesamolin
05/30/2012CN101601840B Medicament for treating hepatolenticular degeneration
05/30/2012CN101579344B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/30/2012CN101570554B Method for preparing zinc supplementing agent carboxymethyl chitosan oligosaccharide zinc
05/30/2012CN101564405B Application of total aglycone of himalayan teasel roots and single-component hederagenin in medicaments preparing Alpha-glucosidase inhibitor
05/30/2012CN101479254B C-phenyl 1-thioglucitol compound
05/30/2012CN101445492B Amide thiazole derivant, preparation method and use thereof
05/30/2012CN101437805B Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
05/30/2012CN101415678B Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists
05/30/2012CN101411693B Oral dosage form for controlled drug release
05/30/2012CN101375928B Pharmaceutical combination for preventing birth-defect and improving memory
05/30/2012CN101375926B Pharmaceutical combination for preventing birth-defect and improving memory
05/30/2012CN101366871B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366870B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366869B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366867B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366778B Medicament composition for preventing birth defection and improving memory
05/30/2012CN101352498B Formulation for improving thirst, polyphagia, hypodynamia and polyuria of diabetes patients
05/30/2012CN101336708B Soya-bean polypeptides weight reduction food
05/30/2012CN101318889B Method of stabilizing reduced coenzyme Q10
05/30/2012CN101278977B Method for extracting main active components of mulberry leaf and application of its extract
05/30/2012CN101248044B Novel indole compounds
05/30/2012CN101225042B Yacon diterpene acid compounds, medicine composition, preparation method and use in preparation of medicine treating diabetes mellitus
05/30/2012CN101123955B 5HT2C receptor modulator compositions and methods of use
05/30/2012CN101085072B Sustained-release tablet containing folium crataegi total flavone
05/30/2012CN101053403B Anti-senility anti-fatigue body-beautifying food and preparation method thereof
05/30/2012CN101032335B Compound health product for reducing blood sugar
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188066 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
05/29/2012CA2649022C Cocrystal of c-glycoside derivative and l-proline
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2490972C Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
05/29/2012CA2482499C Aerosol containing a particulate active substance
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2318731C Ppar-gamma modulators
05/29/2012CA2220777C Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/24/2012WO2012068529A2 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
05/24/2012WO2012068456A2 Compositions and methods for treating obesity
05/24/2012WO2012067427A2 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
05/24/2012WO2012067316A1 Composition for prevention or treatment of metabolic diseases or complications thereof containing pterocarpan-based compounds or pharmaceutically acceptable salts thereof as active ingredient, or composition for antioxidation
05/24/2012WO2012067111A1 PKC-ε ACTIVATOR
05/24/2012WO2012066086A1 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND SULFOBUTYL ETHER 7-ß-CYCLODEXTRIN
05/24/2012WO2012066077A1 1,4 di substituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders
05/24/2012WO2012065996A1 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND MALTOSYL-ß-CYCLODEXTRIN
05/24/2012WO2012065993A1 Vasoprotective and cardioprotective antidiabetic therapy
05/24/2012WO2012065556A1 Process for preparing water extract of cinnamon
05/24/2012WO2012065527A1 Compouds and uses as l-type calcium channel blocker and/or acetylcholinesterase inhibitor thereof
05/24/2012WO2012065362A1 Myomegalin variant 8 and uses thereof
05/24/2012US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics
05/24/2012US20120129934 Methods for the treatment of senile dementia of the alzheimer's type
05/24/2012US20120129932 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/24/2012US20120129930 Ketone compounds and compositions for cholesterol management and related uses
05/24/2012US20120129924 Uses of sesquiterpene derivatives
05/24/2012US20120129923 Pharmaceutical co-crystals of quercetin
05/24/2012US20120129917 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
05/24/2012US20120129911 Compositions and methods of targeting apolipoprotein b for the reduction of apolipoprotein c-iii
05/24/2012US20120129896 Thiazolidinedione analogues for the treatment of metabolic diseases
05/24/2012US20120129891 Sulfone derivative
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 1298